Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 2,000,000 shares at $0.08 ($160K) on 2012-07-31, disclosed to the SEC on 2012-08-01.
Open-market sale of $160k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 151,500 | $12K | 7.6% |
| 2 | $0.08 | 190,000 | $15K | 9.5% |
| 3 | $0.08 | 546,793 | $44K | 27.3% |
| 4 | $0.08 | 611,707 | $49K | 30.6% |
| 5 | $0.08 | 500,000 | $40K | 25.0% |
| Total | $0.08 avg | 2,000,000 |
| $160K |
| 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |
| ACTC | SELL | 2011-09-30 | $109K | — | Filing → |